treatment of acute lymphoblastic leukemia
All entries for: Sumitomo Pharma America Inc.
July 19, 2026
Sumitomo Pharma America Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
treatment of acute lymphoblastic leukemia